CA Stock MarketDetailed Quotes
APLI Appili Therapeutics Inc
- 0.035
- 0.0000.00%
15min DelayMarket Closed Nov 29 16:00 ET
4.24MMarket Cap-1166P/E (TTM)
0.035High0.030Low18.15KVolume0.030Open0.035Pre Close627.00Turnover0.06052wk High0.02%Turnover Ratio121.27MShares0.02552wk Low-0.03EPS TTM3.74MFloat Cap1.890Historical HighLossP/E (Static)106.83MShs Float0.025Historical Low-0.03EPS LYR14.29%Amplitude--Dividend TTM-0.32P/B1Lot Size--Div YieldTTM
Appili Therapeutics Inc Key Stats
Quarterly+Annual
YOY
| (Q2)Sep 30, 2024 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -98.61%4.69K | 0 | 147.60%827.41K | -96.50%11.7K | 478.4K | 337.31K | 0 | -75.97%334.18K | 334.18K | 0 |
| Operating revenue | -98.61%4.69K | --0 | 147.60%827.41K | -96.50%11.7K | --478.4K | --337.31K | --0 | -75.97%334.18K | --334.18K | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | -55.82%333.7K | -77.29%297.1K | -63.13%2.99M | -76.58%597.46K | -86.16%328.91K | -35.67%755.34K | -34.86%1.31M | -67.57%8.11M | 16.59%2.55M | -46.22%2.38M |
| Selling and administrative expenses | -10.73%653.64K | -18.03%764.55K | -31.35%3.05M | -21.57%817.49K | -60.36%564.71K | -18.16%732.23K | -13.41%932.71K | -3.77%4.44M | -5.82%1.04M | 15.09%1.42M |
| -General and administrative expense | -10.73%653.64K | -18.03%764.55K | -31.35%3.05M | -21.57%817.49K | -60.36%564.71K | -18.16%732.23K | -13.41%932.71K | -3.77%4.44M | -5.82%1.04M | 15.09%1.42M |
| Research and development costs | 88.84%2.05M | 55.61%2.02M | 53.04%5.83M | 5.71%1.61M | 83.55%1.83M | 262.26%1.09M | 31.59%1.3M | -82.24%3.81M | 14.02%1.52M | -70.78%998.81K |
| Other operating expenses | -122.99%-2.37M | -169.66%-2.49M | -4,151.87%-5.89M | -11,636.72%-1.83M | -4,317.41%-2.07M | -5,019.14%-1.06M | -1,570.55%-922.58K | 86.97%-138.47K | 93.90%-15.6K | 80.19%-46.84K |
| Operating profit | 21.29%-329.01K | 77.29%-297.1K | 72.19%-2.16M | 73.57%-585.76K | 106.29%149.49K | 64.40%-418.03K | 34.86%-1.31M | 67.07%-7.78M | -1.32%-2.22M | 21.52%-2.38M |
| Net non-operating interest income (expenses) | -24.53%-530.29K | -230.09%-1.23M | -51.40%-1.61M | 13.81%-382.36K | -64.60%-433.05K | -122.63%-425.83K | -121.71%-372.96K | 29.91%-1.07M | 61.27%-443.63K | -11.42%-263.08K |
| Non-operating interest income | --0 | --0 | -43.74%16.81K | -91.50%562 | -40.34%5.58K | -74.19%2.35K | 72.01%8.33K | -11.41%29.88K | 20.83%6.61K | 36.98%9.35K |
| Non-operating interest expense | 23.85%530.29K | 222.88%1.23M | 48.80%1.63M | -14.95%382.92K | 61.00%438.62K | 113.71%428.18K | 120.32%381.29K | -29.51%1.1M | -60.88%450.24K | 12.14%272.43K |
| Other net income (expenses) | 229.03%116.97K | -139.01%-56.71K | 118.01%65.66K | -2,109.62%-126.39K | 152.20%137.31K | 68.52%-90.66K | 205.83%145.39K | -741.72%-364.61K | 1,064.57%6.29K | 56.67%54.44K |
| Gain on sale of security | 229.03%116.97K | -139.01%-56.71K | 118.01%65.66K | -2,109.62%-126.39K | 152.20%137.31K | 68.52%-90.66K | 205.83%145.39K | -741.72%-364.61K | 1,064.57%6.29K | 56.67%54.44K |
| Income before tax | 20.56%-742.33K | -3.18%-1.58M | 59.69%-3.71M | 58.76%-1.09M | 94.34%-146.25K | 43.48%-934.52K | 33.62%-1.54M | 63.29%-9.21M | 20.40%-2.65M | 19.96%-2.59M |
| Income tax | -97.24%1.16K | 0 | 91.20%69.58K | 30.28%8.96K | -82.16%6.09K | 376.91%42.04K | 18.35%12.5K | -5.37%36.39K | 1,764.65%6.88K | 268.09%34.13K |
| Earnings from equity interest net of tax | ||||||||||
| Net income | 23.87%-743.49K | -2.35%-1.58M | 59.09%-3.78M | 58.53%-1.1M | 94.18%-152.34K | 40.39%-976.56K | 33.39%-1.55M | 63.20%-9.24M | 20.18%-2.66M | 19.13%-2.62M |
| Net income continuous operations | 23.87%-743.49K | -2.35%-1.58M | 59.09%-3.78M | 58.53%-1.1M | 94.18%-152.34K | 40.39%-976.56K | 33.39%-1.55M | 63.20%-9.24M | 20.18%-2.66M | 19.13%-2.62M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 23.87%-743.49K | -2.35%-1.58M | 59.09%-3.78M | 58.53%-1.1M | 94.18%-152.34K | 40.39%-976.56K | 33.39%-1.55M | 63.20%-9.24M | 20.18%-2.66M | 19.13%-2.62M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | 23.87%-743.49K | -2.35%-1.58M | 59.09%-3.78M | 58.53%-1.1M | 94.18%-152.34K | 40.39%-976.56K | 33.39%-1.55M | 63.20%-9.24M | 20.18%-2.66M | 19.13%-2.62M |
| Diluted earnings per share | 0.00%-0.01 | 0.00%-0.01 | 62.50%-0.03 | 50.00%-0.01 | 93.72%-0.0013 | 0.00%-0.01 | 66.67%-0.01 | 78.95%-0.08 | 60.00%-0.02 | 60.00%-0.02 |
| Basic earnings per share | 0.00%-0.01 | 0.00%-0.01 | 62.50%-0.03 | 50.00%-0.01 | 93.72%-0.0013 | 0.00%-0.01 | 66.67%-0.01 | 78.95%-0.08 | 60.00%-0.02 | 60.00%-0.02 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CA
Overall
Symbol
Latest Price
% Chg
No Data